Preliminary Program subject to change
TI003 Quality by Design
OverviewSuccesses and Challenges in developing a Design Space, a PAT CMC, or risk based quality systems should be submitted here.
Primary SponsorTopical I: Pharmaceutical Engineering for the 21^st Century (TI)
Co-Sponsor(s)Process Research and Innovation (12a)

Chair

Christine Seymour
Pfizer Global Research & Development
Pfizer
MS 7040-1208
Eastern Point Rd
Groton, CT 06340
Phone Number: 860-686-1011
Email: christine.b.seymour@pfizer.com

CoChair

Huiquan Wu
Chemical Engineer
CDER
FDA
10903 New Hampshire Ave
White Oak LS 64, Room 1080, HFD-940
Silver Spring, MD 20993
Phone Number: 301-796-0022
Fax Number: 301-796-9816
Email: huiquan.wu@fda.hhs.gov
Welcoming Remarks
An Integrated Quality by Design Qbd Approach for Pharmaceutical Powder Blending Unit Operation: Process Monitoring, Endpoint Determination, and Concentration Quantification
Huiquan Wu, CDER, FDA, 10903 New Hampshire Ave, White Oak LS 64, Room 1080, HFD-940, Silver Spring, MD 20993, Mobin Tawakkul, CDER, FDA, 10903 New Hampshire Ave, White Oak LS 64, Room 1026, HFD-940, Silver Spring, MD 20993 and Mansoor A. Khan, CDER, FDA, 10903 New Hampshire Ave, White Oak LS 64, Room 1070, HFD-940, Silver Spring, MD 20993
Quality By Design Using An Integrated Active Pharmaceutical Ingredient-Drug Product Approach To Development
Mary T. am Ende, Oral Products Center of Emphasis, Pfizer, Eastern Point Road, MS 8156-01, Groton, CT 06340, Vincent E. McCurdy, RFT Program Office, Pfizer, Eastern Point Road, Groton, CT 06340, Thomas P. Garcia, Regulatory CMC, Pfizer, Eastern Point Road, Groton, CT 06340, Frank Busch, Process R&D, Pfizer, Eastern Point Road, Groton, CT 06340 and Mark R. Berry, Non-Clinical Statistics, Pfizer, Eastern Point Road, Groton, CT 06340
The Use Of Routine Process Capability In The Determination Of Proven Acceptable Ranges (Pars) Critical Process Parameters (Cpps) And Mapping Of The Design Space For An Api Process
Kevin D. Seibert, Chermical Product Research and Development, Eli Lilly & Co., 1400 W. Raymond St., Indianapolis, IN 46221, Shanthi Sethuraman, MS&T Statistics, Eli Lilly & Co., 1400 W. Raymond St., Indianapolis, IN 46221 and Chad Wolfe, CPR&D, Eli Lilly & Co., 1400 W. Raymond St., Indianapolis, IN 46221
Mathematical Modeling Of The Impact Of Raw Material Variabilities On Granule Particle Size Distribution During Fluidized Bed Granulation
Pavol Rajniak, Ecevit Bilgili and Rey Chern, Merck & Co, Inc., WP78-110, PO Box 4, West Point, PA 19486
Synchronized Approach to Developing Optimal Control and Design Spaces
Jerry D. Mitchell1, Bernard McGarvey2, Kumar Abhinava2, Kevin Seibert2, Shanthi Sethuraman2 and Kristi Griffiths2, (1)Engineering Tech Center, Eli Lilly & Company, Indianapolis, IN 46285, (2)Eli Lilly & Company, Indianapolis, IN 46285
Correlation between Excipient Characteristics and Product Properties through Numerical Simulations of Tablet Compaction
Athanas A. Koynov, Rutgers University, 98 Brett Rd., Piscataway, NJ 08854 and Alberto Cuitino, Mechanical Engineering, Rutgers University, 98 Brett Rd., Piscataway, NJ 08854
Characterizing the Influence of Raw Material and Process Variation on Product Quality and Yields
Chris McCready, Process Analytical Technology, Umetrics Inc., 17 Kiel Ave, Kinnelon, NJ 07045
Panel Discussion

Topical I: Pharmaceutical Engineering for the 21Century